{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T02:16:36Z","timestamp":1795054596447,"version":"4.10.2"},"reference-count":23,"publisher":"Wiley","issue":"11","license":[{"start":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T00:00:00Z","timestamp":1792022400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T00:00:00Z","timestamp":1792022400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"funder":[{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["MR\/Z503769\/1"],"award-info":[{"award-number":["MR\/Z503769\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["224485\/Z\/21\/Z"],"award-info":[{"award-number":["224485\/Z\/21\/Z"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["225868\/Z\/22\/Z"],"award-info":[{"award-number":["225868\/Z\/22\/Z"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Pharmacoepidemiology and Drug"],"published-print":{"date-parts":[[2026,11]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>The COVID\u201019 pandemic disrupted healthcare services, potentially affecting causal effect estimation using real\u2010world data. As a case study, we replicated a cohort study using Clinical Practice Research Datalink Aurum to evaluate whether pandemic\u2010related disruptions influenced the measured association between fluoroquinolone use and tendon rupture.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We included adults initiating fluoroquinolones\/cephalosporins during 1 January 2006\u201331 March 2023. Four analyses compared treatment effect estimates using different periods for exposure and outcome ascertainment: pre\u2010pandemic only, pre\u2010pandemic exposure with follow\u2010up extending through the pandemic, all available data and post\u2010pandemic only. We estimated hazard ratios (HRs) for tendon rupture using Cox regression.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Among 891\u2009968 fluoroquinolone users and 895\u2009229 cephalosporin users, fluoroquinolone users had more comorbidities than cephalosporin users in the pre\u2010pandemic period but fewer in the post\u2010pandemic period. Pre\u2010pandemic analysis showed an increased risk of tendon rupture associated with fluoroquinolones (Propensity score weighted [PSW]\u2010HR: 1.94; 95% CI: 1.46\u20132.59), consistent with previous evidence. Estimates using all available data were similar for the overall study period (PSW\u2010HR: 1.91; 95% CI: 1.46\u20132.51) and the pre\u2010pandemic period (PSW\u2010HR: 1.96; 95% CI: 1.47\u20132.61) but were less precise during\/post\u2010pandemic period (PSW\u2010HR: 1.57; 95% CI: 0.72\u20133.41) with no evidence of a period\u2010treatment interaction (PSW\u2010HR: 0.80; 95% CI: 0.35\u20131.84). Post\u2010pandemic analysis showed very few events among cephalosporin users but not fluoroquinolone users with a larger but imprecise estimate (PSW\u2010HR: 3.32; 95% CI: 0.62\u201317.72).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>In this case study, there was no clear evidence that pandemic\u2010related healthcare disruptions materially altered causal estimates, albeit with limited power to detect differences between before and during\/post\u2010pandemic effects. Studies using real\u2010world data across the pandemic should routinely examine temporal changes in baseline characteristics and outcome incidence.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1002\/pds.70504","type":"journal-article","created":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T01:05:18Z","timestamp":1792112718000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Impact of\n                    <scp>COVID<\/scp>\n                    \u201019 Restrictions on Estimating Causal Effects: Fluoroquinolones and Tendon Rupture"],"prefix":"10.1002","volume":"35","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8618-7333","authenticated-orcid":false,"given":"Angel Y. S.","family":"Wong","sequence":"first","affiliation":[{"name":"Faculty of Epidemiology and Population Health London School of Hygiene and Tropical Medicine  London UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremy P.","family":"Brown","sequence":"additional","affiliation":[{"name":"Faculty of Life Sciences &amp; Medicine King's College London  London UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7194-2615","authenticated-orcid":false,"given":"John","family":"Tazare","sequence":"additional","affiliation":[{"name":"Faculty of Epidemiology and Population Health London School of Hygiene and Tropical Medicine  London UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1481-3331","authenticated-orcid":false,"given":"Marleen","family":"Bokern","sequence":"additional","affiliation":[{"name":"Faculty of Epidemiology and Population Health London School of Hygiene and Tropical Medicine  London UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6905-876X","authenticated-orcid":false,"given":"Elizabeth","family":"Williamson","sequence":"additional","affiliation":[{"name":"Faculty of Epidemiology and Population Health London School of Hygiene and Tropical Medicine  London UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7117-0195","authenticated-orcid":false,"given":"Jonathan","family":"Bartlett","sequence":"additional","affiliation":[{"name":"Faculty of Epidemiology and Population Health London School of Hygiene and Tropical Medicine  London UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4524-3180","authenticated-orcid":false,"given":"Charlotte","family":"Warren\u2010Gash","sequence":"additional","affiliation":[{"name":"Faculty of Epidemiology and Population Health London School of Hygiene and Tropical Medicine  London UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian","family":"Douglas","sequence":"additional","affiliation":[{"name":"Faculty of Epidemiology and Population Health London School of Hygiene and Tropical Medicine  London UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2026,10,15]]},"reference":[{"key":"e_1_2_15_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2022.11.011"},{"key":"e_1_2_15_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2589-7500(21)00017-0"},{"key":"e_1_2_15_4_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n1135"},{"key":"e_1_2_15_5_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2020-047567"},{"key":"e_1_2_15_6_1","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2020.594117"},{"key":"e_1_2_15_7_1","doi-asserted-by":"publisher","DOI":"10.1093\/fampra\/cmac083"},{"key":"e_1_2_15_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajem.2020.11.029"},{"key":"e_1_2_15_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.puhe.2020.08.007"},{"key":"e_1_2_15_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahj.2020.11.004"},{"key":"e_1_2_15_11_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0242653"},{"key":"e_1_2_15_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jfo.2022.02.006"},{"key":"e_1_2_15_13_1","doi-asserted-by":"publisher","DOI":"10.1002\/onco.13791"},{"key":"e_1_2_15_14_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamacardio.2023.2418"},{"key":"e_1_2_15_15_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00228-019-02713-1"},{"key":"e_1_2_15_16_1","unstructured":"E.Mathieu H.Ritchie L.Rod\u00e9s\u2010Guirao et\u00a0al. \u201cCoronavirus Pandemic (COVID\u201019) \u201d 2020 https:\/\/ourworldindata.org\/covid\u2010stringency\u2010index."},{"key":"e_1_2_15_17_1","doi-asserted-by":"publisher","DOI":"10.1002\/pds.4996"},{"key":"e_1_2_15_18_1","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkx504"},{"key":"e_1_2_15_19_1","doi-asserted-by":"publisher","DOI":"10.1111\/resp.12312"},{"key":"e_1_2_15_20_1","doi-asserted-by":"publisher","DOI":"10.1111\/joim.12197"},{"key":"e_1_2_15_21_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.o3020"},{"key":"e_1_2_15_22_1","unstructured":"NHS Business Services Authority \u201cSerious Shortage Protocol (SSP) for Phenoxymethylpenicillin 125\u2009mg\/5mL Oral Solution Sugar Free\u2014Corresponding Guidance on Endorsement Prescription Charges Remuneration and Reimbursement Plus Q&A \u201d 2026 https:\/\/www.nhsbsa.nhs.uk\/sites\/default\/files\/2023\u201001\/240120~2.PDF."},{"key":"e_1_2_15_23_1","unstructured":"Medicines and Healthcare products Regulatory Agency \u201cFluoroquinolone Antibiotics: Reminder of the Risk of Disabling and Potentially Long\u2010Lasting or Irreversible Side Effects \u201d 2023 https:\/\/www.gov.uk\/drug\u2010safety\u2010update\/fluoroquinolone\u2010antibiotics\u2010reminder\u2010of\u2010the\u2010risk\u2010of\u2010disabling\u2010and\u2010potentially\u2010long\u2010lasting\u2010or\u2010irreversible\u2010side\u2010effects."},{"key":"e_1_2_15_24_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.a816"}],"container-title":["Pharmacoepidemiology and Drug Safety"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/pds.70504","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/pds.70504","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/pds.70504","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T01:22:17Z","timestamp":1795051337000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/pds.70504"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,15]]},"references-count":23,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["10.1002\/pds.70504"],"URL":"https:\/\/doi.org\/10.1002\/pds.70504","archive":["Portico"],"relation":{},"ISSN":["1053-8569","1099-1557"],"issn-type":[{"value":"1053-8569","type":"print"},{"value":"1099-1557","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,15]]},"assertion":[{"value":"2026-07-16","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-10-09","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-10-15","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e70504"}}